Header Logo

Connection

DANIEL ROSEN to Cystadenocarcinoma, Serous

Back to Details
This is a "connection" page, showing publications DANIEL ROSEN has written about Cystadenocarcinoma, Serous.
DANIEL ROSEN
Connection Strength
0.233
Cystadenocarcinoma, Serous
  1. CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Jun; 23(5):815-22.
    View in: PubMed
    Score: 0.106
  2. CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol. 2012 Mar; 25(3):456-64.
    View in: PubMed
    Score: 0.095
  3. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer. 2007 Jan 01; 120(1):81-90.
    View in: PubMed
    Score: 0.017
  4. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006 Sep; 19(9):1149-56.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.